ALK-Abelló A/S (AKBLF)
ALK-Abelló A/S, an allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.
$37.92+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+31.0%
The outlook
ALK-Abelló A/S currently reads as leaning bullish based on mixed vs its moving averages, 77% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range77% of the way from its 52-week low to high
Market cap
$8.40B
52-wk high
$40.65
52-wk low
$28.95
50-day avg
$39.45
200-day avg
$35.92
Trailing P/E
43.1